Pepro Tech
A more recent version of this article appeared on December 1, 2007

Published online before print September 20, 2007
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0507292v1
82/6/1501    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ojala, P. J.
Right arrow Articles by Parkkinen, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ojala, P. J.
Right arrow Articles by Parkkinen, J.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0507292


Received for publication May 9, 2007.
Revised July 28, 2007.
Accepted for publication August 24, 2007.


Article

Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils

P. J. Ojala *, T. E. Hirvonen *, M. Hermansson {dagger}, P. Somerharju {dagger}, and J. Parkkinen *{ddagger}@

*Finnish Red Cross Blood Service, Helsinki, Finland; {dagger}Institute of Biomedicine, Department of Biochemistry, University of Helsinki, Helsinki, Finland; and {ddagger}Department of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland

@ To whom correspondence should be addressed. E-mail: jaakko.parkkinen{at}helsinki.fi.


arrow
Abstract

Lysophosphatidylcholine (LPC) is the most abundant lysophospholipid in plasma and tissues, and its level increases in ischemia and inflammation. LPC induces various proinflammatory actions in leukocytes, endothelial cells, and smooth muscle cells, but its effects may vary, depending on the acyl chain. In the present study, we identified the molecular species of LPC in human plasma and studied their effects on human neutrophils. Unsaturated LPC species over a wide concentration range (5–200 µM) induced long-lasting superoxide production in neutrophils. The response was preceded by a >10-min lag time and lasted for 60–90 min. Superoxide production was prevented when albumin was added together with LPC at a molar ratio of 1:2 or higher, and significant inhibition was observed even when albumin was added 4–8 min after LPC. Saturation of albumin by fivefold molar excess of stearic acid reduced the inhibitory effect significantly. Saturated LPCs, particularly the most abundant 16:0 species, induced significantly less superoxide production than the unsaturated species and only at 5–10 µM concentrations. Saturated LPC species elicited a several-fold higher increase in cytoplasmic calcium and at >20 µM, increased plasma membrane permeability. A mixture of LPCs mimicking the plasma LPC composition induced nearly similar superoxide production as the most active LPC18:1 alone. These results indicate remarkable acyl chain-dependent differences in the cellular effects of LPC. Elevation of LPC level may increase inflammation through activation of neutrophil NADPH oxidase, particularly when the simultaneous increase of free fatty acids diminishes the ability of albumin to scavenge LPCs.

Key Words: superoxide • NADPH oxidase • albumin • free fatty acids • ischemia




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
X. Zhao, A. Peter, J. Fritsche, M. Elcnerova, A. Fritsche, H.-U. Haring, E. D. Schleicher, G. Xu, and R. Lehmann
Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?
Am J Physiol Endocrinol Metab, February 1, 2009; 296(2): E384 - E393.
[Abstract] [Full Text] [PDF]